Edition:
United States

Cytosorbents Corp (CTSO.OQ)

CTSO.OQ on NASDAQ Stock Exchange Capital Market

8.17USD
3:59pm EST
Change (% chg)

$-0.11 (-1.33%)
Prev Close
$8.28
Open
$8.38
Day's High
$8.40
Day's Low
$8.15
Volume
29,740
Avg. Vol
53,993
52-wk High
$14.90
52-wk Low
$6.70

Chart for

About

CytoSorbents Corporation is a critical care focused immunotherapy company. The Company is engaged in commercializing its product, CytoSorb, which is a blood purification technology with focus in preventing or treating multiple organ failure. The Company's purification technologies are based on biocompatible, porous polymer beads... (more)

Overall

Beta: 1.59
Market Cap(Mil.): $262.08
Shares Outstanding(Mil.): 31.65
Dividend: --
Yield (%): --

Financials

  CTSO.OQ Industry Sector
P/E (TTM): -- 69.36 36.06
EPS (TTM): -0.50 -- --
ROI: -64.42 6.23 12.72
ROE: -101.24 8.77 13.74

Earnings vs. Estimates